EcoDrugPlus

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSVPAG00000006183
Gene Symbol: FDFT1
1 Cross references
215 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSVPAG00000001160
Gene Symbol: FNTA
1 Cross references
216 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSVPAG00000006378
Gene Symbol: FNTB
1 Cross references
210 Possible Orthologues:

Fibroblast Activation Protein Alpha

Ensembl ID : ENSVPAG00000010821
Gene Symbol: FAP
1 Cross references
127 Possible Orthologues:

Fibroblast Growth Factor 2

Ensembl ID : ENSVPAG00000010536
Gene Symbol: FGF2
1 Cross references
117 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSVPAG00000006520
Gene Symbol: FGFR2
1 Cross references
216 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 1

Ensembl ID : ENSVPAG00000006361
Gene Symbol: FLT1
1 Cross references
198 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 3

Ensembl ID : ENSVPAG00000006354
Gene Symbol: FLT3
1 Cross references
133 Possible Orthologues:

Folate Hydrolase 1

Ensembl ID : ENSVPAG00000011316
Gene Symbol: FOLH1
1 Cross references
210 Possible Orthologues:

Folate Receptor Alpha

Ensembl ID : ENSVPAG00000005386
Gene Symbol: FOLR1
1 Cross references
217 Possible Orthologues:

Follicle Stimulating Hormone Receptor

Ensembl ID : ENSVPAG00000002207
Gene Symbol: FSHR
1 Cross references
199 Possible Orthologues:

Fyn Related Src Family Tyrosine Kinase

Ensembl ID : ENSVPAG00000001075
Gene Symbol: FRK
1 Cross references
216 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).